www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News 19 killed in floods in Bolivia    Dead swans test positive for H5N1 bird flu in Germany    Hamas rejects Annan's call to disarm: leader    ISRAELI ACTING PM SAYS TO REVIEW CONTACTS WITH PALESTINIANSIF HAMAS FORMS CABINET    Saddam Hussien trial adjourns for two weeks    SADDAM HUSSEIN TRIAL RESUMES IN BAGHDAD ON TUESDAY    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Source Manufacturers and Suppliers from China and around the world
   News Photos Voice People BizChina Feature About us   
US Study: vitamin pills don't protect against prostate cancer
www.chinaview.cn 2006-02-15 12:52:04

    WASHINGTON, Feb. 14 (Xinhuanet) -- Taking pills of antioxidants doesn't help prevent prostate cancer, showed a National Cancer Institute (NCI) study published on Tuesday.

    The study, involving about 30,000 men, is among many large studies that seek to confirm if antioxidants, taken in the form of pills instead of in diet, can help protect against prostate cancer. Previous studies have yielded conflicting results.

    About 1,340 men were diagnosed with prostate cancer within eight years of entering the NCI study. Among them, those who took antioxidant supplements made no difference except for some smokers,the study revealed.

    In the study, the possibility for smokers who had taken high doses of vitamin E for years to be diagnosed with advanced prostate cancers dropped 71 percent. Meanwhile, the risk of earlier-stage cancer increased among those vitamin E-using smokers.

    As smoking itself increases the risk of prostate cancer, quitting smoking would be more helpful, said Harvard University scientists in an accompanying editorial in Tuesday's Journal of the National Cancer Institute, where the result of the study was published.

    The report said the study was primarily intended to test the value of screening tests for prostate cancer. Enditem

  Related Story
Jolie, Pitt move to Paris
Saddam Hussein trial adjourns for 2 weeks
China finishes 2-3 in women's 500m speed skating
- China spends US$40 bln buying US planes
- Foreign investors pose no security threat: Chinese banker
- Iran confirms uranium-enrichment resumption
- China chides US for criticism over trade, yuan
- Commissioner on China IPR protection
- Regulation of Internet in line with world norms: China
- China rejects charges on covert agents in US
- Morgan Stanley in talks to buy Chinese broker
- Iran confirms uranium-enrichment resumption
- ROK expects success in race for top UN post
- Rumsfeld winds up North Africa visits
- Sharon's son sentenced to 9 months in jail
- Britain to ban smoking in pubs, clubs
- Danish FM says cartoon conflict could last 100 years
- Kenyan ministers resign over corruption scandals
- U.S. denies "plot" with Israel to oust Hamas
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.